Temporal Patterns and Factors Associated with Early Termination in Phase 1 Clinical Trials for Solid Tumors

Phase 1 trials are primarily discontinued for "sponsor/strategic decisions". Funding source, tumor type, and geographic location of recruiting centers are independently associated with ET. The early peak in ET probability marks a critical window for interventions to improve trial sustainability.